Lates News

A federal judge in the United States has ruled that Eli Lilly and Company can continue to pursue its lawsuit against Mochi Health Corp., which sells generic versions of its obesity and diabetes drugs. Judge Jacqueline Scott Corley of the Northern District of California federal district court stated in an order submitted on Monday that Eli Lilly has demonstrated that Mochi Health's actions have harmed the pharmaceutical company's business and the reputation of its FDA-approved drug tirzepatide.